183 results on '"Orit Pinhas-Hamiel"'
Search Results
2. Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experience
- Author
-
Judith Nir, Marianna Rachmiel, Abigail Fraser, Yael Lebenthal, Avivit Brener, Orit Pinhas-Hamiel, Alon Haim, Eve Stern, Noa Levek, Tal Ben-Ari, and Zohar Landau
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism - Published
- 2023
3. MiniMed 780G Advanced Hybrid Closed Loop System Outcomes According to Pubertal Status - Awesome Study Group Real-Life Experience
- Author
-
Marianna Rachmiel, Yael Lebenthal, Kineret Mazor-Aronovitch, Avivit Brener, Noah Levek, Talia Jacobi-Polishook, Tal Ben Ari, Shirli Abiri, Zohar Landau, and Orit Pinhas-Hamiel
- Subjects
Medical Laboratory Technology ,Endocrinology ,Endocrinology, Diabetes and Metabolism - Published
- 2023
4. Myopia and BMI: a nationwide study of 1.3 million adolescents
- Author
-
Alon Peled, Itay Nitzan, Jacob Megreli, Estela Derazne, Dorit Tzur, Orit Pinhas‐Hamiel, Arnon Afek, and Gilad Twig
- Subjects
Male ,Nutrition and Dietetics ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,Body Mass Index ,Obesity, Morbid ,Cross-Sectional Studies ,Endocrinology ,Thinness ,Risk Factors ,Myopia ,Humans ,Female - Abstract
This study analyzed the association between adolescent BMI and myopia severity.This cross-sectional study comprised 1,359,153 adolescents who were medically examined before mandatory military service. Mild-to-moderate and high myopia were defined based on right-eye refractive data. BMI was categorized based on the US age- and sex-matched percentiles. Logistic regression models were applied separately for women and men to estimate odds ratios (ORs) for myopia per BMI category.A total of 318,712 adolescents had mild-to-moderate myopia and 23,569 had high myopia. Compared with low-normal BMI (reference group), adjusted ORs for mild-to-moderate and high myopia increased with increasing BMI status, reaching 1.39 (95% CI: 1.23-1.57) and 1.73 (95% CI: 1.19-2.51) for men with severe obesity, respectively, and 1.19 (95% CI: 1.12-1.27) and 1.38 (95% CI: 1.14-1.65) for women with mild obesity, respectively. ORs for mild-to-moderate and high myopia were also higher in men with underweight (OR = 1.20; 95% CI: 1.18-1.23 and OR = 1.39; 95% CI: 1.30-1.47) and women with underweight (OR = 1.06; 95% CI: 1.03-1.09 and OR = 1.12; 95% CI: 1.04-1.22). The overall size effect was greater for men than women (pBMI was associated with myopia in a J-shaped pattern, with the size effect being greater for adolescent men than women. This study indicates that both low BMI and high BMI are associated with mild-to-moderate and severe myopia.
- Published
- 2022
5. A Novel Mutation in the Thyroglobulin Gene Resulting in Neonatal Goiter and Congenital Hypothyroidism in an Eritrean Infant
- Author
-
Adeline K Nicholas, Eran Kassif, Nadia Schoenmakers, Orit Pinhas Hamiel, Eve Stern, and Yonatan Yeshayahu
- Subjects
0301 basic medicine ,endocrine system ,medicine.medical_specialty ,Goiter ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Levothyroxine ,030209 endocrinology & metabolism ,Eritrea ,Thyroglobulin ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Congenital Hypothyroidism ,medicine ,Humans ,Fetus ,Pregnancy ,Nucleotides ,business.industry ,Thyroid ,medicine.disease ,Exon skipping ,Congenital hypothyroidism ,Fetal Diseases ,030104 developmental biology ,medicine.anatomical_structure ,Mutation ,Pediatrics, Perinatology and Child Health ,Female ,business ,medicine.drug - Abstract
Congenital Hypothyroidism (CH) due to dyshormonogenesis may occur due to mutations in any of the key genes involved in thyroid hormone biosynthesis (TG, TPO, DUOX2, DUOXA2, SLC5A5, IYD, SLC26A4 and SLC26A7). Mutations in the Thyroglobulin gene (TG) are frequently associated with goiter, which may present fetally or neonatally, although a spectrum of phenotypes is reported. We present the case of a woman of Eritrean origin who presented in the third trimester of pregnancy in the early stages of labor. Ultrasound at presentation revealed a fetal neck swelling consistent with a goiter. Following delivery by caesarian section with minimal respiratory support, the infant was found to be hypothyroid with undetectable serum levels of thyroglobulin. Sequencing of the thyroglobulin gene revealed a homozygous donor splice site pathogenic variant (c.5686+1delG) not previously described in the literature. Levothyroxine treatment resulted in normal growth and psychomotor development. Goitrous CH with inappropriately low thyroglobulin has previously been reported in patients harbouring homozygous single nucleotide substitutions at the same TG donor splice site which result in exon skipping and Endoplasmin Reticulum retention of TG. We conclude that the TG c.5686+1delG pathogenic variant is the likely basis for our patient's fetal goiter and congenital hypothyroidism, and that the clinical phenotype associated with TG c.5686+1delG is comparable to that seen with single nucleotide substitutions at the same site.
- Published
- 2022
6. Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthood
- Author
-
Noah Gruber, Lilach Marom Haham, Hila Raanani, Yoram Cohen, LidiaV. Gabis, Michal Berkenstadt, Liat Ries-Levavi, Shai Elizur, and Orit Pinhas-Hamiel
- Subjects
Adult ,Metabolic Syndrome ,Fragile X Mental Retardation Protein ,Nutrition and Dietetics ,Fragile X Syndrome ,Endocrinology, Diabetes and Metabolism ,Mutation ,Humans ,Medicine (miscellaneous) ,Female ,Primary Ovarian Insufficiency ,Cardiology and Cardiovascular Medicine - Abstract
Women with primary ovarian insufficiency exhibit an unfavorable cardiovascular risk profile. A common cause for primary ovarian insufficiency is fragile X premutation (FXPC), and data on the cardiovascular risk factors in women with FXPC are scarce. We aimed to assess the prevalences of abnormal metabolic components among FXPC.Clinical, anthropometric and laboratory data were collected from 71 women with FXPC and compared to 78 women referred for counseling in an in-vitro fertilization clinic (control group). The mean ± SD ages of the FXPC and control groups were 33.5 ± 5.6 and 36.2 ± 5.3 years, respectively (p = 0.003). In a logistic regression analysis, the FXPC group had increased risks for hyperglycemia, hypertriglyceridemia, central obesity and low high-density lipoprotein cholesterol, of 21.8-fold (95% CI 2.7-175, p = 0.004), 6.9-fold (95% CI 2.5-18.7, p 0.0001), 3.1-fold (95% CI 1.4-6.9, p = 0.005) and 2.4-fold (95% CI 1.1-5.2, p = 0.03), compared to the control group. The FXPC group had 2.7-fold higher prevalence of two abnormal metabolic components; 19% met the full criteria of MetS, compared to 3% of the control group. Neither CGG repeats nor ovarian reserve markers were associated with metabolic risk.Carriers of fragile X premutation are at increased metabolic risk from early adulthood; waist circumference, glucose and lipid levels are particularly elevated. We recommend metabolic screening for all women with FMR1 premutation, to enable early interventions for prevention of long-term cardiovascular comorbidities.
- Published
- 2022
7. The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control
- Author
-
Smadar Shilo, Anastasia Godneva, Marianna Rachmiel, Tal Korem, Yuval Bussi, Dmitry Kolobkov, Tal Karady, Noam Bar, Bat Chen Wolf, Yitav Glantz-Gashai, Michal Cohen, Nehama Zuckerman Levin, Naim Shehadeh, Noah Gruber, Neriya Levran, Shlomit Koren, Adina Weinberger, Orit Pinhas-Hamiel, and Eran Segal
- Subjects
Adult ,Blood Glucose ,Advanced and Specialized Nursing ,Feces ,Diabetes Mellitus, Type 1 ,Blood Glucose Self-Monitoring ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,Humans ,Glycemic Control ,Gastrointestinal Microbiome - Abstract
OBJECTIVE Previous studies have demonstrated an association between gut microbiota composition and type 1 diabetes (T1D) pathogenesis. However, little is known about the composition and function of the gut microbiome in adults with longstanding T1D or its association with host glycemic control. RESEARCH DESIGN AND METHODS We performed a metagenomic analysis of the gut microbiome obtained from fecal samples of 74 adults with T1D, 14.6 ± 9.6 years following diagnosis, and compared their microbial composition and function to 296 age-matched healthy control subjects (1:4 ratio). We further analyzed the association between microbial taxa and indices of glycemic control derived from continuous glucose monitoring measurements and blood tests and constructed a prediction model that solely takes microbiome features as input to evaluate the discriminative power of microbial composition for distinguishing individuals with T1D from control subjects. RESULTS Adults with T1D had a distinct microbial signature that separated them from control subjects when using prediction algorithms on held-out subjects (area under the receiver operating characteristic curve = 0.89 ± 0.03). Linear discriminant analysis showed several bacterial species with significantly higher scores in T1D, including Prevotella copri and Eubacterium siraeum, and species with higher scores in control subjects, including Firmicutes bacterium and Faecalibacterium prausnitzii (P < 0.05, false discovery rate corrected for all). On the functional level, several metabolic pathways were significantly lower in adults with T1D. Several bacterial taxa and metabolic pathways were associated with the host’s glycemic control. CONCLUSIONS We identified a distinct gut microbial signature in adults with longstanding T1D and associations between microbial taxa, metabolic pathways, and glycemic control indices. Additional mechanistic studies are needed to identify the role of these bacteria for potential therapeutic strategies.
- Published
- 2022
8. Supervising Without Controlling: A New Authority intervention for Adolescents with Type 1 Diabetes
- Author
-
Yael Rothman-Kabir, Naama Gershy, Orit Pinhas-Hamiel, and Haim Omer
- Subjects
Developmental and Educational Psychology ,Life-span and Life-course Studies - Published
- 2022
9. Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the <scp>COVID</scp> ‐19 pandemic in Israel
- Author
-
Shira Goldman, Orit Pinhas‐Hamiel, Adi Weinberg, Adi Auerbach, Alina German, Alon Haim, Amnon Zung, Avivit Brener, David Strich, Erez Azoulay, Floris Levy‐Khademi, Hanna Ludar, Ilana Koren, Marianna Rachmiel, Michal Yackobovitch‐Gavan, Nehama Zuckerman‐Levin, Odeya David, Rana Halloun, Ranit Cahn, Tal Ben‐Ari, Yonatan Yeshayahu, Zohar Landau, Moshe Phillip, and Yael Lebenthal
- Subjects
Male ,Adolescent ,SARS-CoV-2 ,Incidence ,Endocrinology, Diabetes and Metabolism ,COVID-19 ,Comorbidity ,Diabetic Ketoacidosis ,Diabetes Mellitus, Type 1 ,Population Surveillance ,Pediatrics, Perinatology and Child Health ,Internal Medicine ,Humans ,Female ,Israel ,Child ,Pandemics ,Follow-Up Studies ,Retrospective Studies - Abstract
To evaluate the incidence and severity of ketoacidosis (DKA) at type 1 diabetes diagnosis during the first wave of the coronavirus disease 2019 (COVID-19) pandemic in Israel.A population-based study the product of a national collaboration of Israeli pediatric diabetes centers investigated the presentation of childhood-onset type 1 diabetes. The frequencies of DKA and severe DKA observed during the COVID-19 period from March 15, 2020 (commencement of the first nationwide lockdown) until June 30, 2020 were compared with the same periods in 2019, 2018, and 2017 using multivariable logistic regression, adjusting for age, sex, and socioeconomic position.During the COVID-19 period, DKA incidence was 58.2%, significantly higher than in 2019 (adjusted OR [aOR] 2.18 [95% CI, 1.31-3.60], P = 0.003); 2018 (aOR 2.05 [95% CI, 1.26-3.34], P = 0.004); and 2017 (aOR, 1.79 [95% CI, 1.09-2.93], P = 0.022). The incidence of severe DKA was 19.9%, significantly higher than in 2018 (aOR, 2.49 [95% CI, 1.20-5.19], P = 0.015) and 2017 (aOR, 2.73 [95% CI, 1.28-5.82], P = 0.009). In 2020, admissions and duration of stay in the intensive care unit were higher than in previous years (P = 0.001). During the COVID-19 pandemic, children aged 6-11 years had higher incidences of DKA (61.3% vs. 34.0%, 40.6%, and 45.1%, respectively, P = 0.012), and severe DKA (29.3% vs. 15.1%, 10.9%, and 5.9%, respectively, P = 0.002).The dramatic increase in DKA at presentation of childhood-onset type 1 diabetes during the COVID-19 pandemic mandates targeted measures to raise public and physician awareness.
- Published
- 2021
10. Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
- Author
-
Noah Gruber, Ehud Barhod, Orit Pinhas-Hamiel, Sharon Sheinvald, Amir Tirosh, Moran Rathaus, Rina Hemi, Idit Ron, Amit Tirosh, and Rinat Livne
- Subjects
Type 1 diabetes ,medicine.medical_specialty ,Diabetic ketoacidosis ,business.industry ,Endocrinology, Diabetes and Metabolism ,Insulin ,medicine.medical_treatment ,medicine.disease ,Ketoacidosis ,NEFA ,Endocrinology ,Blood chemistry ,Diabetes mellitus ,Internal medicine ,Ketogenesis ,Internal Medicine ,medicine ,business - Abstract
Fatty acid-binding protein 4 (FABP4) is an adipokine with a key regulatory role in glucose and lipid metabolism. We prospectively evaluated the role of FABP4 in the pathophysiology of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes. Clinical and laboratory data were prospectively collected from consecutive children presenting with new-onset type 1 diabetes. In addition to blood chemistry and gases, insulin, C-peptide, serum FABP4 and NEFA were collected upon presentation and 48 h after initiation of insulin treatment. In a mouse model of type 1 diabetes, glucose, insulin, β-hydroxybutyrate and weight were compared between FABP4 knockout (Fabp4−/−) and wild-type (WT) mice. Included were 33 children (mean age 9.3 ± 3.5 years, 52% male), of whom 14 (42%) presented with DKA. FABP4 levels were higher in the DKA group compared with the non-DKA group (median [IQR] 10.1 [7.9–14.2] ng/ml vs 6.3 [3.9–7] ng/ml, respectively; p = 0.005). The FABP4 level was positively correlated with HbA1c at presentation and inversely correlated with venous blood pH and bicarbonate levels (p
- Published
- 2021
11. Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data
- Author
-
Nehama Zuckerman Levin, Yitav Glantz-Gashai, Naim Shehadeh, Eran Segal, Tal Karady, Bat Chen Wolf, Adina Weinberger, Smadar Shilo, Neriya Levran, Orit Pinhas-Hamiel, Dmitry Kolobkov, Shlomit Koren, Noam Bar, Tal Korem, Marianna Rachmiel, Noah Gruber, Anastasia Godneva, and Michal Cohen
- Subjects
Adult ,Blood Glucose ,Research design ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Humans ,Insulin ,Prospective Studies ,Child ,Prospective cohort study ,Meals ,Glycemic ,Advanced and Specialized Nursing ,Type 1 diabetes ,Meal ,Cross-Over Studies ,business.industry ,Blood Glucose Self-Monitoring ,Postprandial Period ,medicine.disease ,Diabetes Mellitus, Type 1 ,Postprandial ,business - Abstract
OBJECTIVE Despite technological advances, results from various clinical trials have repeatedly shown that many individuals with type 1 diabetes (T1D) do not achieve their glycemic goals. One of the major challenges in disease management is the administration of an accurate amount of insulin for each meal that will match the expected postprandial glycemic response (PPGR). The objective of this study was to develop a prediction model for PPGR in individuals with T1D. RESEARCH DESIGN AND METHODS We recruited individuals with T1D who were using continuous glucose monitoring and continuous subcutaneous insulin infusion devices simultaneously to a prospective cohort and profiled them for 2 weeks. Participants were asked to report real-time dietary intake using a designated mobile app. We measured their PPGRs and devised machine learning algorithms for PPGR prediction, which integrate glucose measurements, insulin dosages, dietary habits, blood parameters, anthropometrics, exercise, and gut microbiota. Data of the PPGR of 900 healthy individuals to 41,371 meals were also integrated into the model. The performance of the models was evaluated with 10-fold cross validation. RESULTS A total of 121 individuals with T1D, 75 adults and 46 children, were included in the study. PPGR to 6,377 meals was measured. Our PPGR prediction model substantially outperforms a baseline model with emulation of standard of care (correlation of R = 0.59 compared with R = 0.40 for predicted and observed PPGR respectively; P < 10−10). The model was robust across different subpopulations. Feature attribution analysis revealed that glucose levels at meal initiation, glucose trend 30 min prior to meal, meal carbohydrate content, and meal’s carbohydrate-to-fat ratio were the most influential features for the model. CONCLUSIONS Our model enables a more accurate prediction of PPGR and therefore may allow a better adjustment of the required insulin dosage for meals. It can be further implemented in closed loop systems and may lead to rationally designed nutritional interventions personally tailored for individuals with T1D on the basis of meals with expected low glycemic response.
- Published
- 2021
12. Youth-onset type 2 diabetes mellitus: an urgent challenge
- Author
-
Petter, Bjornstad, Lily C, Chao, Melanie, Cree-Green, Allison B, Dart, Malcolm, King, Helen C, Looker, Dianna J, Magliano, Kristen J, Nadeau, Orit, Pinhas-Hamiel, Amy S, Shah, Daniel H, van Raalte, Meda E, Pavkov, and Robert G, Nelson
- Abstract
The incidence and prevalence of youth-onset type 2 diabetes mellitus (T2DM) and its complications are increasing worldwide. Youth-onset T2DM has been reported in all racial and ethnic groups, but Indigenous peoples and people of colour are disproportionately affected. People with youth-onset T2DM often have a more aggressive clinical course than those with adult-onset T2DM or those with type 1 diabetes mellitus. Moreover, the available treatment options for children and adolescents with T2DM are more limited than for adult patients. Intermediate complications of youth-onset T2DM, such as increased albuminuria, often develop in late childhood or early adulthood, and end-stage complications, including kidney failure, develop in mid-life. The increasing frequency, earlier onset and greater severity of childhood obesity in the past 50 years together with increasingly sedentary lifestyles and an increasing frequency of intrauterine exposure to diabetes are important drivers of the epidemic of youth-onset T2DM. The particularly high risk of the disease in historically disadvantaged populations suggests an important contribution of social and environmental factors, including limited access to high-quality health care, healthy food choices and opportunities for physical activity as well as exposure to stressors including systemic racism and environmental pollutants. Understanding the mechanisms that underlie the development and aggressive clinical course of youth-onset T2DM is key to identifying successful prevention and management strategies.
- Published
- 2022
13. Differences in severity of cardiovascular anomalies in children with Noonan syndrome based on the causative gene
- Author
-
Nagham, Shehade-Awwad, Yonatan, Yeshayahu, Orit, Pinhas-Hamiel, and Uriel, Katz
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
BackgroundNoonan syndrome (NS) is a genetic syndrome, characterized by various dysmorphic features, cardiac anomalies, short stature, and developmental delay. NS is a leading cause of cardiovascular anomalies. The syndrome results from dysregulation in the RAS-MAPK pathway and is related to the RASopathy family syndromes. Pathogenic variants in more than 20 related genes have been identified in association with NS, and several genotype-phenotype correlations were suggested. The specific severity of the same cardiovascular anomalies has not been described as linked to a specific causative gene.MethodsFor this retrospective, single-center study, data retrieved from medical charts of a multidisciplinary NS clinic included genetic diagnosis, cardiac malformations, the need for intervention, demographics, and prenatal diagnosis. We analyzed molecular genetics and the severity of cardiac malformations.ResultsThe cohort comprised 74 children with NS. Consistent with previous studies, pathogenic variants in PTPN11 were the most common (62%). Cardiovascular anomalies presented in 57%; pulmonary stenosis (PS) was the most common (about 79% of anomalies). In children with pathogenic variants in PTPN11, PS tended to be more severe and required intervention in 53%, compared to 25% of children with PS and a variant in other genes.ConclusionThis first Israeli cohort of NS showed similar rates of cardiac malformations and genetic breakdown as previously published. Variants in PTPN11 were prone to a higher risk for severe PS that requires intervention. This finding may assist in genetic counseling and cardiac treatment decisions, and stresses the importance of genetic in addition to clinical diagnosis of NS.
- Published
- 2022
14. Cover Image
- Author
-
Nehama Zuckerman Levin, Meidan Cohen, Moshe Phillip, Ariel Tenenbaum, Ilana Koren, Yardena Tenenbaum‐Rakover, Osnat Admoni, Eli Hershkovitz, Alon Haim, Kineret Mazor Aronovitch, David Zangen, David Strich, Avivit Brener, Yonatan Yeshayahu, Yossi Schon, Marianna Rachmiel, Tal Ben‐Ari, Floris Levy‐Khademi, Rami Tibi, Ram Weiss, Yael Lebenthal, Orit Pinhas‐Hamiel, and Naim Shehadeh
- Subjects
Endocrinology, Diabetes and Metabolism ,Pediatrics, Perinatology and Child Health ,Internal Medicine - Published
- 2022
15. RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
- Author
-
Gilad Twig, Inbar Zucker, Yair Zloof, Yaron Cohen, Aya Bardugo, Avishai Tsur, Miri Lutski, Tali Cukierman-Yaffe, Noga Minsky, Estela Derazne, Cheli Melzer-Cohen, Dorit Tzur, Orit Pinhas-Hamiel, Gabriel Chodick, Itamar Raz, Hertzel Gerstein, and Amir Tirosh
- Subjects
Endocrinology, Diabetes and Metabolism - Abstract
Aims Studies in children reported an association between increased body mass index (BMI) and risk for developing type 1 diabetes (T1D), but evidence in late adolescence is limited. We recently investigated the association between adolescent BMI and type 2 diabetes in young adulthood (Diabetes Care 2020, 43(7): 1487-95) and here we studied on the same cohort the association between late adolescent BMI and incident T1D. Methods All Israeli adolescents, ages 16-19, undergoing medical evaluation in preparation for mandatory military conscription between January 1996 and December 2016 were included for analysis unless they had a history of dysglycemia (n=1,462,362; 40% women). Data were linked to information about adult onset of T1D in the Israeli National Diabetes Registry. Weight and height were measured at study entry and BMI was computed and transformed to age- and sex-adjusted BMI percentiles according to US Center for Diseases Control. The definition of T1D was determined based on anti-diabetic drugs and was confirmed for a subpopulation of the cohort to which islet autoantibodies data were available. Cox proportional models were applied, with BMI analyzed both as a categorical and continuous variable. Results There were 777 incident cases of T1D during 15,810,751 person-years (mean age at diagnosis 25.2±3.9 years). The median follow-up period was 11.2 years (IQR 5.8-16.3), with follow-up length shorter for individuals with a higher BMI. The crude diabetes rate showed a consistent graded increase across BMI groups from underweight to obesity; 3.6 to 8.4 cases per 100,000 person-years, respectively. In a multivariable model adjusted for age, sex and socio-demographic variables, the hazard ratios (HRs) for T1D were 1.05 (95% CI 0.87-1.27) for the 50th–74th BMI percentiles, 1.41 (1.11–1.78) for the 75th–84th BMI percentiles, 1.54 (1.23–1.94) for adolescents with overweight (85th–94th percentiles), and 2.05 (1.58–2.66) for adolescents with obesity (BMI≥95th percentile)(reference group, 5th-49th BMI percentile group). One increment in BMI standard deviation was associated with 25% greater risk for incidence of T1D (HR=1.25, 95%CI 1.17-1.32). when the presence of one or multiple (≥2) islet antibodies was added as a criterion for T1D definition, the HRs among those with adolescent obesity were 2.90 (1.80-4.68) and 3.14 (1.68-5.88) respectively. Results were marginally affected by level of adjustment for sociodemographic background, were similar when analysis was stratified by sex, and also persisted when the study population was limited to adolescents with unimpaired health in order to mitigate confounding by coexisting illness. The fraction of type 1 diabetes attributed to adolescent overweight and obesity (Population attributable risk%; PAR%) was 10.1% (95%CI 6.3%-14.2%). Conclusions Adolescent overweight and obesity in apparently healthy adolescents were associated with increased risk for incident type 1 diabetes in early adulthood. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 1:24 p.m. - 1:30 p.m.
- Published
- 2022
16. Correction to: Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
- Author
-
Iren Zargari, Adi Adar, Iris Morag, Orit Pinhas-Hamiel, Ori Eyal, Rimona Keidar, Neta Loewenthal, Milana Levy, Orna Dally-Gottfried, Zohar Landau, Floris Levy-Khademi, Smadar Eventov-Friedman, David Zangen, Ilan Youngster, and Marianna Rachmiel
- Subjects
Pediatrics, Perinatology and Child Health - Published
- 2022
17. Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence
- Author
-
Cole D. Bendor, Aya Bardugo, Ran Shmuel Rotem, Estela Derazne, Hertzel C. Gerstein, Dorit Tzur, Orit Pinhas-Hamiel, Avishai M. Tsur, Tali Cukierman-Yaffe, Yael Lebenthal, Arnon Afek, Gabriel Chodick, and Gilad Twig
- Subjects
Advanced and Specialized Nursing ,Adult ,Blood Glucose ,Male ,Pediatric Obesity ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Infant, Newborn ,Overweight ,Body Mass Index ,Diabetes, Gestational ,Pregnancy ,Glucose Intolerance ,Internal Medicine ,Humans ,Female - Abstract
OBJECTIVE Gestational hyperglycemia is associated with deleterious neonatal outcomes, but long-term risks for offspring obesity are less clear. We estimated the odds for offspring adolescent overweight and obesity among mothers with gestational glucose intolerance. RESEARCH DESIGN AND METHODS In a mother-offspring historical cohort, the Israel military conscription data set was linked to a large health maintenance organization. Included were women who were evaluated at adolescence and underwent two-step gestational diabetes screening (mean age, 31 years) with a 50-g glucose challenge test (GCT), followed by a 100-g oral glucose tolerance test (OGTT) if the result was abnormal. Glucose tolerance categories included gestational normoglycemia, abnormal GCT with normal OGTT, impaired glucose tolerance (IGT; one abnormal OGTT value), and gestational diabetes. The primary outcome was offspring overweight/obesity (BMI ≥85th percentile) at adolescence, measured prior to military conscription. Logistic regression models were applied. RESULTS Of 33,482 mother-offspring pairs, overweight and obesity were observed in 6,516 offspring. Across increasing categories of pregnancy glycemia, the proportions of offspring with adolescent overweight/obesity increased: normoglycemia, 19%; abnormal GCT with normal OGTT, 22%; gestational IGT, 24%; and gestational diabetes, 25% (P < 0.0001). Corresponding odds ratios after adjustment for the mother’s late adolescent characteristics (sociodemographic confounders and BMI) and pregnancy age were 1.2 (95% CI 1.1–1.4), 1.3 (1.2–1.5), and 1.4 (1.3–1.6), respectively. Further adjustment for offspring birth weight percentile and sociodemographic variables did not materially change results. Associations were more pronounced with increasing obesity severity. CONCLUSIONS Gestational glucose intolerance, including categories not meeting the gestational diabetes threshold, was associated with increased odds for offspring overweight/obesity at late adolescence.
- Published
- 2022
18. 1048-P: Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence
- Author
-
COLE D. BENDOR, AYA BARDUGO, RAN ROTEM, ESTELA DERAZNE, HERTZEL C. GERSTEIN, DORIT TZUR, ORIT PINHAS-HAMIEL, AVISHAI M. TSUR, TALI CUKIERMAN-YAFFE, YAEL LEBENTHAL, ARNON AFEK, GABRIEL CHODICK, and GILAD TWIG
- Subjects
Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
Objective: Gestational hyperglycemia is associated with deleterious neonatal outcomes, but long-term risks for offspring obesity are less clear. We estimated the odds for offspring adolescent overweight and obesity among mothers with gestational glucose intolerance. Methods: In a mother-offspring, historical cohort, the Israel military conscription dataset was linked to a large health maintenance organization. Included were women who were evaluated at adolescence and performed two-step gestational diabetes screening (mean age, 31 years) with a 50-g glucose challenge test (GCT) , followed by a 100-g oral glucose tolerance test (OGTT) if abnormal. Glucose tolerance categories included gestational normoglycemia, abnormal GCT with normal OGTT, impaired glucose tolerance (IGT; one abnormal OGTT value) , and gestational diabetes. The primary outcome was offspring overweight/obesity (BMI≥85th percentile) at adolescence, measured prior to military conscription. Logistic regression models were applied. Results: Of 33,482 mother-offspring pairs, overweight and obesity were observed in 6,516 offspring. Across increasing categories of pregnancy glycemia, the proportions of offspring with adolescent overweight/obesity increased: normoglycemia, 19%; abnormal GCT with normal OGTT, 22%; gestational IGT, 24%; and gestational diabetes, 25%, P Conclusions: Gestational glucose intolerance, including categories not meeting the gestational diabetes threshold, were associated with increased odds for offspring overweight/obesity at late adolescence. Disclosure C.D.Bendor: None. Y.Lebenthal: Advisory Panel; Lilly, Novo Nordisk, Research Support; Novo Nordisk, Pfizer Inc., Speaker's Bureau; Pfizer Inc. A.Afek: None. G.Chodick: None. G.Twig: None. A.Bardugo: None. R.Rotem: None. E.Derazne: None. H.C.Gerstein: Advisory Panel; Abbott, Eli Lilly and Company, Hanmi Pharm. Co., Ltd., Novo Nordisk, Pfizer Inc., Sanofi, Viatris Inc., Consultant; Kowa Company, Ltd., Other Relationship; DKSH, Eli Lilly and Company, Sanofi, Zuellig Pharma Holdings Pte. Ltd., Research Support; AstraZeneca, Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk, Sanofi. D.Tzur: None. O.Pinhas-hamiel: Advisory Panel; Novo Nordisk, Speaker's Bureau; Pfizer Inc. A.M.Tsur: None. T.Cukierman-yaffe: Research Support; European Association for the Study of Diabetes, Medtronic, Merck Sharp & Dohme Corp., Novo Nordisk, Speaker's Bureau; AstraZeneca, Eli Lilly and Company, Medtronic, Merck Sharp & Dohme Corp., Novo Nordisk, Sanofi.
- Published
- 2022
19. 1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood
- Author
-
INBAR ZUCKER, YAIR ZLOOF, AYA BARDUGO, AVISHAI M. TSUR, MIRI LUTSKI, YARON COHEN, TALI CUKIERMAN-YAFFE, NOGA MINSKY, ESTELA DERAZNE, DORIT TZUR, CHELI MELZER COHEN, ORIT PINHAS-HAMIEL, GABRIEL CHODICK, ITAMAR RAZ, ARNON AFEK, HERTZEL C. GERSTEIN, AMIR TIROSH, and GILAD TWIG
- Subjects
Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
Background: Studies in children reported an association between increased body mass index (BMI) and risk for developing type 1 diabetes (T1D) . We studied the association between adolescent BMI and incident T1D in young adulthood in a nationwide cohort of 1,462,362 adolescents which was recently used to assess the association between adolescent BMI and early-onset type 2 diabetes (Diabetes Care 2020 Jul;43 (7) :1487-1495) . Methods: All Israeli adolescents, ages 16-19, undergoing medical evaluation in preparation for mandatory military conscription between January 1996 and December 2016 were included for analysis unless they had a history of dysglycemia. Data were linked to information about adult onset of T1D in the Israeli National Diabetes Registry. Weight and height were measured at the study entry. Cox proportional models were applied, with BMI analyzed both as a categorical and as a continuous variable. Islet autoantibody data were available for a subpopulation of the cohort. Results: There were 777 incident cases of T1D during 15,810,751 person-years (mean age at diagnosis 25.2±3.9 years) . BMI was associated with incident T1D. In a multivariable model adjusted for age, sex and socio-demographic variables, the hazard ratios (HRs) for T1D were 1. (95% CI 0.87-1.27) for the 50th-74th BMI percentiles, 1.41 (1.11-1.78) for the 75th-84th BMI percentiles, 1.54 (1.23-1.94) for adolescents with overweight (85th-94th percentiles) , and 2. (1.58-2.66) for adolescents with obesity (BMI≥95th percentile) . One increment in BMI standard deviation was associated with 25% greater risk for incidence of T1D (HR=1.25, 95%CI 1.17-1.32) . Association persisted when the definition of T1D included the presence of islet autoantibodies; when the study population was restricted to those with unimpaired health. Conclusions: Excessively high BMI in apparently healthy adolescents is associated with increased risk for incident T1D in early adulthood. Disclosure I.Zucker: None. D.Tzur: None. C.Melzer cohen: None. O.Pinhas-hamiel: Advisory Panel; Novo Nordisk, Speaker's Bureau; Pfizer Inc. G.Chodick: None. I.Raz: None. A.Afek: None. H.C.Gerstein: Advisory Panel; Abbott, Eli Lilly and Company, Hanmi Pharm. Co., Ltd., Novo Nordisk, Pfizer Inc., Sanofi, Viatris Inc., Consultant; Kowa Company, Ltd., Other Relationship; DKSH, Eli Lilly and Company, Sanofi, Zuellig Pharma Holdings Pte. Ltd., Research Support; AstraZeneca, Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk, Sanofi. A.Tirosh: Advisory Panel; Abbott Diagnostics, AstraZeneca, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Novo Nordisk, Sanofi, Consultant; Bayer AG, DreaMed Diabetes, Ltd., Research Support; Medtronic, Speaker's Bureau; Eli Lilly and Company. G.Twig: None. Y.Zloof: None. A.Bardugo: None. A.M.Tsur: None. M.Lutski: None. Y.Cohen: None. T.Cukierman-yaffe: Research Support; European Association for the Study of Diabetes, Medtronic, Merck Sharp & Dohme Corp., Novo Nordisk, Speaker's Bureau; AstraZeneca, Eli Lilly and Company, Medtronic, Merck Sharp & Dohme Corp., Novo Nordisk, Sanofi. N.Minsky: None. E.Derazne: None. Funding This work was partially supported by an internal grant from the Israel Defense Forces Medical Corps.
- Published
- 2022
20. Stuttering and Incident Type 2 Diabetes: A Population-Based Study of 2.2 Million Adolescents
- Author
-
Arnon Afek, Itamar Raz, Limor Friedensohn, Hertzel C. Gerstein, Tali Cukierman-Yaffe, Estela Derazne, Inbar Zucker, Amir Tirosh, Ofer Amir, Miri Lutski, Ofri Mosenzon, Avishai M Tsur, Orit Pinhas-Hamiel, Dorit Tzur, Gilad Twig, Maya Fischman, Asaf Vivante, Shir Hershkovich, and Jacob Rotchild
- Subjects
Male ,medicine.medical_specialty ,Stuttering ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,030209 endocrinology & metabolism ,Type 2 diabetes ,Biochemistry ,Cohort Studies ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Risk Factors ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Registries ,Israel ,Young adult ,education ,Socioeconomic status ,education.field_of_study ,business.industry ,Incidence ,Biochemistry (medical) ,Odds ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,Female ,medicine.symptom ,business ,Body mass index ,030217 neurology & neurosurgery ,Demography - Abstract
Purpose To investigate the association between stuttering in adolescence and incident type 2 diabetes in young adulthood. Methods This nationwide population-based study included 2 193 855 adolescents of age 16 to 20 years who were assessed for military service between 1980 and 2013. Diagnoses of stuttering in adolescence were confirmed by a speech-language pathologist. Diabetes status for each individual as of December 31, 2016, was determined by linkage to the Israeli National Diabetes Registry. Relationships were analyzed using regression models adjusted for socioeconomic variables, cognitive performance, coexisting morbidities, and adolescent body mass index. Results Analysis was stratified by sex (Pinteraction = 0.035). Of the 4443 (0.4%) adolescent men with stuttering, 162 (3.7%) developed type 2 diabetes, compared with 25 678 (2.1%) men without stuttering (adjusted odds ratio [OR] 1.3; 95% CI, 1.1-1.6). This relationship persisted when unaffected brothers of men with stuttering were used as the reference group (adjusted OR = 1.5; 95% CI, 1.01-2.2), or when the analysis included only adolescents with unimpaired health at baseline (adjusted OR = 1.4; 95% CI, 1.1-1.7). The association was stronger in later birth cohorts, with an adjusted OR of 2.4 (1.4-4.1) for cases of type 2 diabetes before age 40. Of the 503 (0.1%) adolescent women with stuttering 7 (1.4%) developed type 2 diabetes, compared with 10 139 (1.1%) women without stuttering (OR = 2.03; 95% CI, 0.48-2.20). Conclusions Adolescent stuttering is associated with an increased risk for early-onset type 2 diabetes among men.
- Published
- 2021
21. Obesity and sleep disorders: A nationwide study of 1.3 million Israeli adolescents
- Author
-
Hagay Frenkel, Gilad Twig, Dorit Tzur, Avi Shina, Neta Geva, Aviv Goldbart, Orit Pinhas-Hamiel, Arnon Afek, and Estela Derazne
- Subjects
Male ,Sleep Wake Disorders ,0301 basic medicine ,Percentile ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Overweight ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Prevalence ,medicine ,Humans ,Obesity ,Sleep disorder ,030109 nutrition & dietetics ,Nutrition and Dietetics ,business.industry ,Confounding ,Odds ratio ,medicine.disease ,Sleep in non-human animals ,Cross-Sectional Studies ,Female ,medicine.symptom ,business ,Body mass index - Abstract
Objectives To assess the association between sleep disorders prevalence and obesity in Israeli adolescents. Methods A nationwide, population-based, cross-sectional study of 1,348,817 Israeli adolescents (57% males) who were medically examined prior to military service between 1997 and 2015; height and weight were measured along with assessment of medical status at age 17.3⬰±⬰0.4 years. The diagnosis of a sleep disorder was made based on objective diagnostic criteria. The prevalence and odds ratio (OR) for a sleep disorder were computed across BMI subgroups and were adjusted for socio-demographic confounders. Results Overall sleep disorders prevalence was 1.8:1000 (males) and 0.45:1000 (females), with a total of 1601 cases. There was a gradual increase in the odds ratio for sleep disorders with increasing BMI. Multivariable-adjusted ORs for sleep disorders were 1.29 (95% CI 1.10⬜1.52), 1.44 (1.18⬜1.75), 3.03 (2.32⬜3.96) and 3.38 (1.98⬜5.75) for overweight, obese class I, II and III, respectively (5th⬜49th BMI percentile was the reference). Results persisted in extensive sensitivity analyses including limiting the study sample to participants with unimpaired health. Conclusions We found a higher prevalence of sleep disorders in males and a dose-dependent association between sleep disorders and adolescent BMI in both sexes. Our findings warrant clinical awareness among healthcare providers, given the rise in obesity in teenagers, and particularly in light of the obesity epidemic that we are experiencing in this era. Sleep related complaints should be actively screened in adolescents who suffer obesity.
- Published
- 2020
22. Early exposures and inherent factors in premature newborns are associated with type 1 diabetes
- Author
-
Iren, Zargari, Adi, Adar, Iris, Morag, Orit, Pinhas-Hamiel, Ori, Eyal, Rimona, Keidar, Neta, Loewenthal, Milana, Levy, Orna, Dally-Gottfried, Zohar, Landau, Floris, Levy-Khademi, Smadar, Eventov-Friedman, David, Zangen, Ilan, Youngster, and Marianna, Rachmiel
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
Pathophysiology of type 1 diabetes (T1D) involves immune responses that may be associated with early exposure to environmental factors among preterm newborns. The aim of this work was to evaluate for association between T1D and maternal, nutritional, and medical exposures during the neonatal period among premature newborns.This is a multicenter, matched case-control study. Preterm newborns, who developed T1D before 18 years, were matched by sex, gestational age (GA), birth date, and medical center of birth with newborns who did not develop TID. Data included maternal medical history, birth weight (BW), length of hospitalization, enteral and parenteral medications, fluid administration, and feeding modalities during hospitalization.Fifty-two patients with T1D, 26 males, median age at T1D diagnosis 8.17 years (5.92-9.77), median GA 34 weeks (33-m36), and 132 matched controls, were included. Multivariate-conditional-regression demonstrated a significant association between T1D and any maternal illness (23.1% vs. 9.1%, OR = 4.99 (1.69-14.72), p = 0.004), higher BW-SDS (0.07 ± 0.95 vs. -0.27 ± 0.97, OR = 2.03 (1.19-3.49), p = 0.01), longer duration of glucose infusion (3 (1-5) days vs. 2 (0-4), OR = 1.23 (1.03-1.46), p = 0.02), and antibiotic therapy beyond the first week of life (19.2% vs. 6.9%, OR = 5.22 (1.32-20.70), p = 0.019). Antibiotic treatment during the first week of life was negatively associated with T1D (51.9% vs. 67.2%, OR 0.31 (0.11-0.88), p = 0.027).A novel association was demonstrated between the development of T1D and early interventions and exposures among preterm newborns.Type 1 diabetes mellitus during childhood may be associated with early exposures during the neonatal period, in addition to known maternal and neonatal metabolic parameters. Early exposure to intravenous antibiotics, differing between the first week of life and later, and longer parenteral glucose administration to preterm newborns were associated with childhood type 1 diabetes. This is in addition to familiar maternal risk factors. Future prospective studies should examine the microbial changes and immune system characteristics of preterm and term neonates exposed to parenteral antibiotics and glucose treatment, in order to validate our exploratory findings.
- Published
- 2022
23. Youth-onset type 2 diabetes in Israel: A national cohort
- Author
-
Nehama Zuckerman Levin, Meidan Cohen, Moshe Phillip, Ariel Tenenbaum, Ilana Koren, Yardena Tenenbaum‐Rakover, Osnat Admoni, Eli Hershkovitz, Alon Haim, Kineret Mazor Aronovitch, David Zangen, David Strich, Avivit Brener, Yonatan Yeshayahu, Yossi Schon, Marianna Rachmiel, Tal Ben‐Ari, Floris Levy‐Khademi, Rami Tibi, Ram Weiss, Yael Lebenthal, Orit Pinhas‐Hamiel, and Naim Shehadeh
- Subjects
Cohort Studies ,Glycated Hemoglobin ,Adolescent ,Diabetes Mellitus, Type 2 ,Endocrinology, Diabetes and Metabolism ,Pediatrics, Perinatology and Child Health ,Internal Medicine ,Humans ,Female ,Israel ,Child ,Metformin - Abstract
Prevalence of youth-onset type 2 diabetes (T2D) has increased worldwide, paralleling the rise in pediatric obesity. Occurrence and clinical manifestations vary regionally and demographically.We assessed the incidence, and clinical and demographic manifestations of youth-onset T2D in Israel.In a national observational study, demographic, clinical, and laboratory data were collected from the medical records of children and adolescents, aged 10-18 years, diagnosed with T2D between the years 2008 and 2019.The incidence of youth-onset T2D in Israel increased significantly from 0.63/100,000 in 2008 to 3.41/100,000 in 2019. The study cohort comprised 379 individuals (228 girls [59.7%], 221 Jews [58.3%], mean age 14.7 ± 1.9 years); 73.1% had a positive family history of T2D. Mean body mass index (BMI) z-score was 1.96 ± 0.7, higher in Jews than Arabs. High systolic (≥ 130 mmHg) and diastolic blood pressure (≥ 85 mmHg) were observed in 33.7% and 7.8% of patients, respectively; mean glycosylated hemoglobin (A1c) level at diagnosis was 8.8 ± 2.5%. Dyslipidemia, with high triglyceride (150 mg/dl) and low HDL-c (40 mg/dl) levels, was found in 45.6% and 56.5%, respectively. Microalbuminuria and retinopathy were documented at diagnosis, 15.2% and 1.9%, respectively) and increased (36.7% and 4.6%, respectively) at follow-up of 2.9 ± 2.1 years. Criteria of metabolic syndrome were met by 224 (62.2%) patients, and fatty liver documented in 65%, mainly Jews. Psychosocial comorbidity was found in 31%. Treatment with metformin (45.6%), insulin (20.6%), and lifestyle modification (18%) improved glycemic control.Youth-onset T2D in Israel has increased significantly and presents a unique profile.
- Published
- 2022
24. Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood
- Author
-
Miri Lutski, Boris Fishman, Zohar Levi, Dana Ben-Ami Shor, Amir Tirosh, Zivan Beer, Tali Cukierman-Yaffe, Gilad Twig, Michal Ben-Ami, Dorit Tzur, Aya Bardugo, Hans-Ulrich Häring, Inbar Zucker, Arnon Afek, Itamar Raz, Cole D. Bendor, Hertzel C. Gerstein, Estela Derazne, Orit Pinhas-Hamiel, and Ofri Mosenzon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,030209 endocrinology & metabolism ,Context (language use) ,Type 2 diabetes ,Biochemistry ,Body Mass Index ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Non-alcoholic Fatty Liver Disease ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Nonalcoholic fatty liver disease ,medicine ,Humans ,030212 general & internal medicine ,Age of Onset ,Israel ,Young adult ,education ,Adolescence ,Nafld ,Type 2 Diabetes ,Young Adults ,education.field_of_study ,business.industry ,Incidence ,Incidence (epidemiology) ,Biochemistry (medical) ,Hazard ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,Female ,business ,Follow-Up Studies - Abstract
Context The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. Objective To assess type 2 diabetes risk among adolescents with NAFLD. Design and Setting A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997–2011 and were followed until December 31, 2016. Participants A total of 1 025 796 normoglycemic adolescents were included. Interventions Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. Main Outcome Measures Type 2 diabetes incidence. Results During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47–4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). Conclusions Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.
- Published
- 2020
25. Prospective Longitudinal Assessment of Linear Growth and Adult Height in Female Adolescents With Anorexia Nervosa
- Author
-
Adi Enoch-Levy, Daniel Stein, Amit Yaroslavsky, Orit Pinhas-Hamiel, Yael Levy-Shraga, Brigitte Kochavi, Anat Toledano, Sharon Iron-Segev, and Dalit Modan-Moses
- Subjects
050103 clinical psychology ,medicine.medical_specialty ,Pediatrics ,030309 nutrition & dietetics ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Context (language use) ,Anorexia nervosa ,Biochemistry ,03 medical and health sciences ,Endocrinology ,Internal medicine ,Linear regression ,medicine ,0501 psychology and cognitive sciences ,0303 health sciences ,business.industry ,05 social sciences ,Biochemistry (medical) ,Bone age ,medicine.disease ,Malnutrition ,Observational study ,Complication ,business ,Body mass index - Abstract
ContextGrowth retardation is an established complication of anorexia nervosa (AN); however, findings concerning the adult height of AN patients are inconsistent.ObjectiveThe objective of this work was to assess linear growth and adult height in female adolescents with AN.Design and SettingA prospective observational study was conducted in a tertiary university hospital.ParticipantsParticipants included all 255 female adolescent AN patients hospitalized in the pediatric psychosomatic department between January 1, 2000 and May 31, 2015.InterventionsHeight and weight were assessed at admission and during hospitalization. Patients were subsequently invited for measurement of adult height. Additional data collected included premorbid height data, menstrual history, skeletal age, pertinent laboratory studies, and parental heights.Main Outcome MeasureThe main outcome measure of this study was adult height.ResultsMean age at admission was 15.4 ± 1.75 years, mean body mass index (BMI) was 15.7 ± 1.8 kg/m2 (BMI SDS = –2.3 ± 1.45 kg/m2). Premorbid height SD scores (SDS) were not significantly different from those expected in normal adolescents (0.005 ± 0.96). However, height SDS at admission (–0.36 ± 0.99), discharge (–0.34 ± 0.96), and at adult height (–0.29 ± 0.95), were significantly (P ConclusionsWhereas the premorbid height of female adolescent AN patients is normal, linear growth retardation is a prominent feature of their illness. Weight restoration is associated with catch-up growth, but complete catch-up is often not achieved.
- Published
- 2020
26. Good Health Practices and Well-Being among Adolescents with Type-1 Diabetes: A Cross-Sectional Study Examining the Role of Satisfaction and Frustration of Basic Psychological Needs
- Author
-
Lika Hatzir, Rivka Tuval-Mashiach, Orit Pinhas-Hamiel, and Tamar Silberg
- Subjects
Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health ,chronic illness ,health behaviors ,self-determination theory ,psychological needs - Abstract
Type 1 diabetes (T1D) is a chronic disease requiring medical adherence. However, among adolescents, non-adherence rates may reach up to 75%. Satisfaction or frustration with psychological needs is a crucial factor in the motivation and management of health-related behaviors. This study aimed to examine the differences in good health practices and psychological and physical well-being among adolescents with and without T1D and the mediating role of satisfaction and frustration of psychological needs on the association between good health practices and well-being in this population. A total of 94 adolescents (42 with T1D, 52 healthy controls, mean age 14.83 ± 1.82 years) completed questionnaires assessing good health practices, satisfaction or frustration of psychological needs, and well-being. Adolescents with T1D reported lower levels of physical well-being compared to healthy controls. Satisfaction or frustration of psychological needs had an effect on good health practices and psychological and physical well-being among healthy controls. Among adolescents with T1D, satisfaction or frustration of psychological needs was related to psychological well-being and partially related to physical well-being, but not to good health practices. The results demonstrate that the satisfaction or frustration of psychological needs has a unique effect on health behaviors and well-being among adolescents with T1D. This calls for further examination of the underlying mechanisms involved in health-related behaviors and well-being among adolescents with T1D.
- Published
- 2023
27. Impact of Immigration on Body Mass Index and Blood Pressure Among Adolescent Males and Females
- Author
-
Karl Skorecki, Estela Derazne, Orit Pinhas-Hamiel, Ehud Grossman, Aya Bardugo, Gilad Twig, Dorit Tzur, Arnon Afek, Avi Itzhak, Uri Hamiel, Asaf Vivante, Amir Tirosh, Doron M. Behar, Cole D. Bendor, and Zivan Beer
- Subjects
Male ,Adolescent ,Health Status ,media_common.quotation_subject ,Immigration ,Blood Pressure ,Risk Assessment ,Body Mass Index ,Young Adult ,Internal Medicine ,Humans ,Medicine ,Obesity ,Israel ,Retrospective Studies ,media_common ,business.industry ,Incidence ,Emigration and Immigration ,medicine.disease ,Black or African American ,Cross-Sectional Studies ,Blood pressure ,Jews ,Hypertension ,Multivariate Analysis ,Female ,Ethiopia ,business ,Body mass index ,Demography - Abstract
Immigration from one cultural milieu to another has been associated with a greater risk for incident cardio-metabolic morbidity among adults. In this nationwide, population-based, cross-sectional study of data recorded from 1992 to 2016, we assessed the association between body mass index and blood pressure levels among adolescent immigrants, aged 16 to 19 years, of Ethiopian origin, and their secular trend of overweight and obesity. Adolescents of Ethiopian origin were classified as Israeli-born (n=16 153) or immigrants (N=23 487), with stratification by age at immigration. Adolescents whose fathers were at least 3 generations in Israel (n=277 789) served as a comparative group. Hypertensive-range blood pressure values adjusted for age, sex, and height served as outcome. Among adolescents of Ethiopian origin, overweight and obesity (body mass index ≥85th percentile), increased by 2.5 and 4-fold in males and females, respectively, during the study period, compared with a 1.5-fold increase among native Israeli-born males and females. The odds for hypertensive-range measurements increased with the length of residence in Israel: 7.3%, 10.6%, and 14.4% among males who immigrated at ages 12 to 19, 6 to 11.9, and 0 to 5.9 years, respectively; and 11.5%, 16.7%, and 19.3%, respectively, among females. Israeli-born Ethiopians had a significantly higher risk for hypertensive-range measurements at any body mass index level compared with native Israeli-born examinees, after adjusting for sociodemographic factors and health status. In conclusion, among Ethiopian Israeli adolescents, abnormal blood pressure correlates directly with the time-lapse since immigration. Immigrant populations require targeted surveillance and appropriate intervention.
- Published
- 2019
28. Childhood Pancreatitis and Risk for Incident Diabetes in Adulthood
- Author
-
Ari Sapir, Ofri Mosenzon, Amir Tirosh, Hertzel C. Gerstein, Dorit Tzur, Estela Derazne, Gilad Twig, Arnon Afek, Inbar Zucker, Itamar Raz, Orit Pinhas-Hamiel, Tammy Shohat, Miri Lutski, Richard G. Kibbey, Aya Bardugo, Tali Cukierman-Yaffe, and Cole D. Bendor
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Population ,030209 endocrinology & metabolism ,Type 2 diabetes ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal Medicine ,medicine ,Humans ,Registries ,030212 general & internal medicine ,Age of Onset ,Israel ,Epidemiology/Health Services Research ,Risk factor ,Young adult ,Child ,education ,Advanced and Specialized Nursing ,Type 1 diabetes ,education.field_of_study ,business.industry ,Incidence ,Odds ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,Pancreatitis ,Acute Disease ,Acute pancreatitis ,Female ,business - Abstract
OBJECTIVE The relationship between acute pancreatitis and incident diabetes is unclear. We assessed whether a resolved single event of acute pancreatitis in childhood was associated with incident diabetes in adulthood. RESEARCH DESIGN AND METHODS A nationwide, population-based study of 1,802,110 Israeli adolescents (mean age 17.4 years [range 16–20]) who were examined before compulsory military service between 1979 and 2008 and whose data were linked to the Israeli National Diabetes Registry (INDR). Resolved pancreatitis was defined as a history of a single event of acute pancreatitis with normal pancreatic function at enrollment. Logistic regression analysis was applied. RESULTS Incident diabetes developed in 4.6% of subjects with resolved pancreatitis (13 of 281; none of these cases were identified as type 1 diabetes) and 2.5% among the unexposed group (44,463 of 1,801,716). Resolved acute pancreatitis was associated with incident diabetes with an odds ratio (OR) of 2.23 (95% CI 1.25–3.98) with adjustment for age, sex, and birth year. Findings persisted after further adjustments for baseline BMI and sociodemographic confounders (OR 2.10 [95% CI 1.15–3.84]). Childhood pancreatitis was associated with a diagnosis of diabetes at a younger age, with 92% of diabetes case subjects diagnosed before 40 years of age compared with 47% in the unexposed group (P = 0.002). The association accentuated when the study sample was limited to individuals of unimpaired health or normal BMI at baseline. CONCLUSIONS A history of acute pancreatitis in childhood with normal pancreatic function in late adolescence is a risk factor for incident type 2 diabetes, especially at young adulthood.
- Published
- 2019
29. Obesity in late adolescence and incident type 1 diabetes in young adulthood
- Author
-
Inbar Zucker, Yair Zloof, Aya Bardugo, Avishai M. Tsur, Miri Lutski, Yaron Cohen, Tali Cukierman-Yaffe, Noga Minsky, Estela Derazne, Dorit Tzur, Cheli Melzer Cohen, Orit Pinhas-Hamiel, Gabriel Chodick, Itamar Raz, Arnon Afek, Hertzel C. Gerstein, Amir Tirosh, and Gilad Twig
- Subjects
Adult ,Young Adult ,Diabetes Mellitus, Type 1 ,Adolescent ,Risk Factors ,Endocrinology, Diabetes and Metabolism ,Incidence ,Internal Medicine ,Humans ,Obesity ,Overweight ,Child ,Body Mass Index - Abstract
Studies in children have reported an association between increased BMI and risk for developing type 1 diabetes, but evidence in late adolescence is limited. We studied the association between BMI in late adolescence and incident type 1 diabetes in young adulthood.All Israeli adolescents, ages 16-19 years, undergoing medical evaluation in preparation for mandatory military conscription between January 1996 and December 2016 were included for analysis unless they had a history of dysglycaemia. Data were linked with information about adult onset of type 1 diabetes in the Israeli National Diabetes Registry. Weight and height were measured at study entry. Cox proportional models were applied, with BMI being analysed both as a categorical and as a continuous variable.There were 777 incident cases of type 1 diabetes during 15,819,750 person-years (mean age at diagnosis 25.2±3.9 years). BMI was associated with incident type 1 diabetes. In a multivariable model adjusted for age, sex and sociodemographic variables, the HRs for type 1 diabetes were 1.05 (95% CI 0.87, 1.27) for the 50th-74th BMI percentiles, 1.41 (95% CI 1.11, 1.78) for the 75th-84th BMI percentiles, 1.54 (95% CI 1.23, 1.94) for adolescents who were overweight (85th-94th percentiles), and 2.05 (95% CI 1.58, 2.66) for adolescents with obesity (≥95th percentile) (reference group: 5th-49th BMI percentiles). One increment in BMI SD was associated with a 25% greater risk for incidence of type 1 diabetes (HR 1.25, 95% CI 1.17, 1.32).Excessively high BMI in otherwise healthy adolescents is associated with increased risk for incident type 1 diabetes in early adulthood.
- Published
- 2021
30. Myopia and Body Mass Index: A Nationwide study of 1.3 Million Adolescents. Supplementary Material
- Author
-
Alon Peled, Itay Nitzan, Jacob Megreli, Estela Derazne, Dorit Tzur, Orit Pinhas-Hamiel, Arnon Afek, and Gilad Twig
- Subjects
genetic structures ,eye diseases - Abstract
Supplementary Material Supplementary table 1. The association between adolescent body mass index (BMI) and myopia for men– methodological sensitivity and subgroup analyses Supplementary table 2. The association between adolescent body mass index (BMI) and myopia for women– methodological sensitivity and subgroup analyses
- Published
- 2021
- Full Text
- View/download PDF
31. Adolescent Hypertension and Risk for Early-Onset Type 2 Diabetes: A Nationwide Study of 1.9 Million Israeli Adolescents
- Author
-
Aya Bardugo, Gilad Twig, Hertzel C. Gerstein, Cole D. Bendor, Estela Derazne, Amir Tirosh, Tali Cukierman-Yaffe, Yoav Leiba, Orit Pinhas-Hamiel, Boris Fishman, Arnon Afek, Dorit Tzur, Itamar Raz, Miri Lutski, Omri Orr, Ehud Grossman, Tamar Fishman, Ofri Mosenzon, Inbar Zucker, and Zivan Beer
- Subjects
Advanced and Specialized Nursing ,Pediatrics ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Endocrinology, Diabetes and Metabolism ,Secondary hypertension ,030209 endocrinology & metabolism ,Physical examination ,Retrospective cohort study ,Type 2 diabetes ,medicine.disease ,Essential hypertension ,03 medical and health sciences ,0302 clinical medicine ,Blood pressure ,Cohort ,Internal Medicine ,medicine ,Medical history ,030212 general & internal medicine ,business - Abstract
The incidence of adolescent hypertension is growing worldwide, mostly in conjunction with the growing obesity prevalence (1,2). Adolescent hypertension was shown to be a risk factor for cardiovascular and renal outcomes later in life, thus promoting current guidelines to screen all pediatric and adolescent population for hypertension (1,3). Here, we elucidate the association of adolescent hypertension and early-onset type 2 diabetes in a nationwide cohort of adolescents. In this population-based, retrospective cohort study we linked the Israeli Defense Forces conscription center database with the Israeli National Diabetes Registry (INDR). One year prior to mandatory military service at age 17 years, Israeli adolescents undergo comprehensive medical evaluation based on their medical history, an interview and physical examination that includes measurements of height, weight, and blood pressure. Included were adolescents who were examined between 1 January 1993 and 31 December 2016. Excluded were those with prior diagnosis of dysglycemia and those with missing baseline height or weight data (3.8% in total). Essential hypertension diagnosis was confirmed by a board-specified nephrologist based on a preexisting diagnosis or screening for hypertension as described previously (1). Briefly, adolescents with blood pressure measurement during the screening assessment of >140/90 mmHg were referred for further investigation. The final diagnosis was made when the average of 10 additional outpatient blood pressure measurements was >140/90 mmHg, when at least 50% of the measurements were above this level, and after exclusion of secondary hypertension. The primary outcome was incident type 2 diabetes as documented by the INDR, which captures all cases of diabetes in Israel with a sensitivity of 95.1% (2). Cox models were applied. Follow-up started at the day of the first medical examination and ended at the date of diabetes diagnosis, 31 December 2016, or death—whichever came first. Due to the previously described …
- Published
- 2020
32. Myopia and Early-Onset Type 2 Diabetes: A Nationwide Cohort Study
- Author
-
Inbar Zucker, Gilad Twig, Orit Pinhas-Hamiel, Arnon Afek, Eran Pras, Adi Einan-Lifshitz, Itamar Raz, Dorit Tzur, Hertzel C. Gerstein, Miri Lutski, Estela Derazne, Ofri Mosenzon, Amir Tirosh, Jacob Megreli, Tali Cukierman-Yaffe, Alon Peled, and Yair Morad
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Type 2 diabetes ,Biochemistry ,Cohort Studies ,Young Adult ,Endocrinology ,Sex Factors ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Epidemiology ,medicine ,Myopia ,Humans ,Registries ,Young adult ,Age of Onset ,Israel ,Dioptre ,Retrospective Studies ,business.industry ,Incidence (epidemiology) ,Incidence ,Biochemistry (medical) ,Hazard ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,Female ,Insulin Resistance ,business ,Cohort study - Abstract
Context A correlation between myopia and insulin resistance has been suggested. Objective We investigated the association between myopia in adolescence and type 2 diabetes (T2D) incidence in young adulthood. Methods This population-based, retrospective, cohort study comprised 1 329 705 adolescents (579 543 women, 43.6%) aged 16 to 19 years, who were medically examined before mandatory military service during 1993 to 2012, and whose data were linked to the Israel National Diabetes Registry. Myopia was defined based on right-eye refractive data. Cox proportional models were applied, separately for women and men, to estimate hazard ratios (HRs) for T2D incidence per person-years of follow-up. Results There was an interaction between myopia and sex with T2D (P Conclusion For women, myopia in adolescence was associated with a significantly increased risk for incident T2D in young adulthood, in a severity-dependent manner. This finding may support the role of insulin resistance in myopia pathogenesis.
- Published
- 2021
33. Management of Fully Pubertal Girls With Nonclassical Congenital Adrenal Hyperplasia: Glucocorticoids Versus Oral Contraceptives
- Author
-
Michal Horovitz, Moshe Phillip, Liora Lazar, Galia Barash, Orit Pinhas-Hamiel, Liat de Vries, and Michal Baum
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Hirsutism ,Adolescent ,Pediatric endocrinology ,Endocrinology, Diabetes and Metabolism ,Endocrinology ,Sex hormone-binding globulin ,medicine ,Humans ,Congenital adrenal hyperplasia ,Child ,Glucocorticoids ,hirsutism ,Acne ,Retrospective Studies ,biology ,Adrenal Hyperplasia, Congenital ,business.industry ,Hyperandrogenism ,Androstenedione ,General Medicine ,medicine.disease ,Cohort ,biology.protein ,Female ,business ,Body mass index ,Contraceptives, Oral - Abstract
To compare clinical outcomes of 3 treatment regimens-glucocorticoids (GCs), oral contraceptives (OCs), or a combination of both-administered to adolescents and young women diagnosed in childhood with nonclassical congenital adrenal hyperplasia (NCCAH), who had been treated with GCs until their adult height was achieved.A retrospective study of medical records of 53 female patients with NCCAH followed in 3 tertiary pediatric endocrinology institutes. The 3 treatment groups were compared for the prevalence of hirsutism and acne, standardized body mass index (BMI)-standard deviation score (SDS), and androgen levels at the attainment of adult height (baseline), 1-year later, and at the last documented visit.At baseline, there were no significant differences among groups in BMI-SDS, androgen levels, hirsutism prevalence, acne, or irregular menses. From baseline to the last visit, the rate of hirsutism declined significantly only in the OC group (37.5% vs 6.2%, respectively; P = .03). The rate of acne declined in the combined group (50% vs 9%, respectively; P = .03) with a similar tendency in the OC group (50% vs 12.5%, respectively; P = .05). No significant changes were observed in BMI-SDS for the entire cohort or any subgroup during follow-up. A significant rise in androstenedione (P.001), testosterone (P.01), and 17-hydroxyprogesterone (P.01) levels was observed only in the OC group.In girls diagnosed in childhood with NCCAH, who require treatment for hyperandrogenism following completion of linear growth, management should be tailored individually using a patient-centered approach. Treatment with OCs might be better than that with GCs for regression of hirsutism and acne. The long-term effects of elevated levels of androgens associated with this treatment regimen should be further studied.
- Published
- 2021
34. Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
- Author
-
Noah, Gruber, Moran, Rathaus, Idit, Ron, Rinat, Livne, Sharon, Sheinvald, Ehud, Barhod, Rina, Hemi, Amit, Tirosh, Orit, Pinhas-Hamiel, and Amir, Tirosh
- Subjects
Blood Glucose ,Glycated Hemoglobin ,Male ,Mice, Knockout ,Fatty Acid-Binding Proteins ,Diabetes Mellitus, Experimental ,Diabetic Ketoacidosis ,Mice, Inbred C57BL ,Mice ,Diabetes Mellitus, Type 1 ,Animals ,Humans ,Insulin ,Female ,Prospective Studies ,Child - Abstract
Fatty acid-binding protein 4 (FABP4) is an adipokine with a key regulatory role in glucose and lipid metabolism. We prospectively evaluated the role of FABP4 in the pathophysiology of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes.Clinical and laboratory data were prospectively collected from consecutive children presenting with new-onset type 1 diabetes. In addition to blood chemistry and gases, insulin, C-peptide, serum FABP4 and NEFA were collected upon presentation and 48 h after initiation of insulin treatment. In a mouse model of type 1 diabetes, glucose, insulin, β-hydroxybutyrate and weight were compared between FABP4 knockout (Fabp4Included were 33 children (mean age 9.3 ± 3.5 years, 52% male), of whom 14 (42%) presented with DKA. FABP4 levels were higher in the DKA group compared with the non-DKA group (median [IQR] 10.1 [7.9-14.2] ng/ml vs 6.3 [3.9-7] ng/ml, respectively; p = 0.005). The FABP4 level was positively correlated with HbAFABP4 is suggested to be a necessary regulator of ketogenesis in insulin-deficient states.
- Published
- 2021
35. Body Mass Index in 1.9 Million Adolescents and Stroke in Young Adulthood
- Author
-
Amit Ram, Ran S Rotem, David Tanne, Cole D. Bendor, Boris Fishman, Arnon Afek, Gilad Twig, Ariel Furer, Dorit Tzur, Roy Gilon, Estela Derazne, Carmit Libruder, Yael Hershkovitz, Inbar Zucker, Aya Bardugo, Orit Pinhas-Hamiel, Gal Yaniv, Gabriel Chodick, and Shmuel Tiosano
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Pediatric Obesity ,Adolescent ,Population ,Overweight ,Body Mass Index ,Young Adult ,Risk Factors ,medicine ,Humans ,Young adult ,Israel ,education ,Stroke ,Ischemic Stroke ,Retrospective Studies ,Advanced and Specialized Nursing ,education.field_of_study ,business.industry ,Hazard ratio ,medicine.disease ,Obesity ,Hemorrhagic Stroke ,Cohort ,Female ,Neurology (clinical) ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Body mass index - Abstract
Background and Purpose: There is a continuous rise in the prevalence of adolescent obesity and incidence of stroke among young adults in many Western countries, but the association between them is unclear. Methods: A nationwide population-based study of 1 900 384 Israeli adolescents (58% men; mean age, 17.3 years) who were evaluated before mandatory military service during 1985 and 2013. Body mass index was classified according to the US Center for Disease Control and Prevention percentiles. Primary outcome was a first stroke event as recorded by the Israeli National Stroke Registry between 2014 and 2018. Cox proportional hazard models were applied. Results: There were 1088 first stroke events (921 ischemic and 167 hemorrhagic; mean diagnosis age, 41.0 years). Adolescent body mass index was significantly associated with a graded increase in the risk for any stroke, ischemic stroke, but less so with hemorrhagic stroke. The hazard ratios for the first ischemic stroke event were 1.4 (95% CI, 1.2–1.6), 2.0 (95% CI, 1.6–2.4), and 3.4 (95% CI, 2.7–4.3) for the 50th to 84th percentile, overweight and obese groups, respectively, after adjustment for sex, age, and sociodemographic confounders with the 5th to 49th body mass index percentile group as the reference. The respective hazard ratios after further adjustment for diabetes status were 1.3 (1.1–1.5), 1.6 (1.3–2.0), and 2.4 (1.9–3.1). Results persisted when the cohort was divided by diabetes status and when ischemic stroke before age 30 was the outcome. Conclusions: High adolescent body mass index was associated with ischemic stroke in young adults with or without diabetes. The rising prevalence of adolescent obesity may increase the future burden of stroke in young adults.
- Published
- 2021
36. The association between obesity and hyperhidrosis: A nationwide, cross-sectional study of 2.77 million Israeli adolescents
- Author
-
Estela Derazne, Michal Freireich-Astman, Gilad Twig, Arnon Afek, Tarif Bader, Orit Pinhas-Hamiel, Itay Friedberg, Nadav Astman, Aviv Barzilai, and Jakob D. Wikstrom
- Subjects
Male ,Adolescent ,Cross-sectional study ,business.industry ,Hyperhidrosis ,Comorbidity ,Dermatology ,medicine.disease ,Obesity ,Body Mass Index ,Cross-Sectional Studies ,Environmental health ,Odds Ratio ,Prevalence ,medicine ,Humans ,Female ,Israel ,medicine.symptom ,business - Published
- 2019
37. The association between obesity and secular trend of stature: a nationwide study of 2.8 million adolescents over five decades
- Author
-
Amir Tirosh, Estela Derazne, Gilad Twig, Orit Pinhas-Hamiel, Asaf Vivante, Brian Reichman, Neta Geva, Yair Barak, and Arnon Afek
- Subjects
Percentile ,Nutrition and Dietetics ,business.industry ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,medicine.disease ,Obesity ,Disease control ,Secular variation ,03 medical and health sciences ,0302 clinical medicine ,Height increased ,medicine ,030212 general & internal medicine ,Underweight ,medicine.symptom ,business ,Linear growth ,Body mass index ,Demography - Abstract
Background/objectives It is unclear whether adolescent obesity is associated with limited linear growth. We assessed this association in a nationwide sample of adolescents. Methods We conducted a population-based, study of 2,785,227 Israeli adolescents (60% males) who were examined before military service since 1967 through 2015. Height and weight were measured along with assessment of medical status at age 17.4 ± 0.4 years. The secular trend of height was plotted using United States Center for Disease Control (US CDC) age- and sex-adjusted BMI percentile groups. We accounted for health status at enrollment and computed the expected height based on parental data that was available for 512,978 examinees. Results Over five decades, the mean height increased by 3.1 cm among males, but remained unchanged among females. Among males, gain in height was attained predominantly during the first 25 years and has stabilized since. Males with obesity were taller than their normal-weight and underweight counterparts. Underweight girls had a prominent increase in mean height during the first two decades, exceeding the mean height of their counterparts with obesity by over 2 cm. There was a gradual decrease in the difference between measured and expected height in males and females regardless of BMI status, with the exception of the underweight females who achieved consistently higher stature than expected (≥3 cm). Conclusions During five decades, excessive BMI was not a limiting factor in growth potential compared with normal BMI in both sexes. The only group that exceeded its growth potential, when accounting for expected mid-parental height, were underweight females with unimpaired health.
- Published
- 2019
38. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience
- Author
-
Marianna Rachmiel, Galia Barash, Dikla Pivko-Levy, Zohar Landau, Noah Gruber, Orit Pinhas-Hamiel, and Yael Levy-Shraga
- Subjects
Blood Glucose ,Male ,Insulin pump ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,030209 endocrinology & metabolism ,03 medical and health sciences ,Insulin Infusion Systems ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Humans ,Hypoglycemic Agents ,Insulin ,Medicine ,In real life ,Prospective Studies ,030212 general & internal medicine ,Child ,Glycemic ,Glycated Hemoglobin ,Type 1 diabetes ,business.industry ,Blood Glucose Self-Monitoring ,medicine.disease ,Medical Laboratory Technology ,Diabetes Mellitus, Type 1 ,Patient Satisfaction ,Quality of Life ,Female ,business - Abstract
The use of insulin pumps in pediatric patients with type 1 diabetes (T1D) has expanded; however, data comparing devices remain scarce. We compared glycemic control, technical difficulties, and quality of life (QOL) between pump devices of three companies.This prospective observational trial is based on clinical data retrieved during 12 months of follow-up of pediatric patients who started pump therapy as part of their clinical care in four medical centers. The devices fully reimbursed by the national health insurance are as follows: MiniMed™ 640G, MiniMedOf 113 children (mean age 9.1 ± 4.1 years, 46% females), 68 (60%) used Medtronic devices, 33 (29%) OmniPod, and 12 (11%) Animas devices. Twelve percent of the cohort stopped using the pump during the study period, with no difference according to device. There were no differences between groups regarding mean SMBG values (P = 0.86), insulin TDD (P = 0.24), BMI (P = 0.87), level of insertion site pain or local reaction (P = 0.51), technical problems (P = 0.66), and QOL (P = 0.38). Changes in HbA1c from study initiation to end were also not statistically significant for any of the devices: from 7.99% ± 1.14% to 7.93% ± 0.99% for Medtronic, from 7.71% ± 1.29% to 7.92% ± 1.38% for OmniPod, and from 8.75% ± 1.3% to 7.70% ± 1.33% for Animas (P = 0.63).Pump devices were comparable regarding glycemic control, weight gain, and satisfaction among pediatric patients with T1D.
- Published
- 2019
39. A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps
- Author
-
Yoni Shapira, Efrat Tish, Monica Gaspar, Bruria Sher, Mina Shomer, Rachel Frumkin Ben-David, Marianna Yaron, Noa Levek, Kineret Mazor-Aronovitch, Daniel Sorek, Tali Schiller, and Orit Pinhas-Hamiel
- Subjects
Adult ,Male ,medicine.medical_specialty ,Telemedicine ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,Hypoglycemia ,law.invention ,03 medical and health sciences ,Insulin Infusion Systems ,0302 clinical medicine ,Endocrinology ,Quality of life ,Randomized controlled trial ,law ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Hypoglycemic Agents ,Insulin ,Young adult ,Aged ,Internet ,Type 1 diabetes ,business.industry ,Blood Glucose Self-Monitoring ,General Medicine ,Middle Aged ,medicine.disease ,Diabetes Mellitus, Type 1 ,Female ,business - Abstract
To examine the effectiveness and safety over a 12-month period of a telemedicine intervention in adults with type 1 diabetes (T1D) treated with insulin pumps. 74 T1D patients on insulin pumps for at least 1 year (mean 19.5 [11.5] years) and HbA1c ≥ 6.5% (≥ 48 mmol/mol) were randomized to the telemedicine (n = 37) or the standard care group (n = 37). The intervention group was instructed to download data from insulin pumps and glucometers monthly. They received immediate phone feedback and recommendations for insulin dose adjustment; and face-to-face visits once in 6 months, compared to once every 3 months for the standard care group. Satisfaction with treatment, quality of life and frequency of hypoglycemic events was evaluated. The mean changes in HbA1c adjusted to baseline were − 0.08% (0.25 mmol/mol) vs. − 0.01% (0.03 mmol/mol), in the intervention and control groups, respectively (p = 0.18) at 12 months, without an increased frequency of hypoglycemia. Patients in the intervention group felt satisfied and interested in continuing with the treatment (p = 0.04). The quality of life scores were similar in both groups. Direct total costs were 24% less in the intervention group, and indirect total costs decreased by 22% compared to the year preceding the study. Internet-based insulin dose adjustment is as effective and safe as routine care in adults with type 1 diabetes treated by insulin pumps. For suitable patients, some of the time-consuming routine visits may be replaced by user-friendly digital medicine. Clinical Trial.gov Identifier NCT01887431.
- Published
- 2019
40. Bodyweight Measures and Lifestyle Habits in Individuals with Multiple Sclerosis and Moderate to Severe Disability
- Author
-
Moran Livne-Margolin, Gil Harari, Anat Achiron, Orit Pinhas-Hamiel, and Itay Tokatly Latzer
- Subjects
medicine.medical_specialty ,obesity ,Waist ,Overweight ,multiple sclerosis ,Article ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,Internal medicine ,medicine ,overweight ,Medical history ,030212 general & internal medicine ,Prospective cohort study ,Expanded Disability Status Scale ,central obesity ,business.industry ,Multiple sclerosis ,expanded disability status scale ,General Medicine ,medicine.disease ,Obesity ,nervous system diseases ,Medicine ,medicine.symptom ,business ,Body mass index ,030217 neurology & neurosurgery - Abstract
Multiple sclerosis (MS) is a chronic disease marked by progressive disability and decreased mobility over time. We studied whether individuals with MS of higher disability levels will be more overweight/obese as a result of their immobility and/or recurrent steroid treatments. In a prospective study, 130 individuals with MS and significant disability were classified according to the Expanded Disability Status Scale (EDSS) score as belonging to four groups: EDSS 3.0–4.0 (n = 31, 24%), EDSS 4.5–5.5 (n = 24, 18%), EDSS = 6.0 (n = 44, 34%) and EDSS ≥ 6.5 (n = 31, 24%). Medical history, body mass index (BMI), waist circumference and the level of engagement in physical activity were obtained. The mean ± standard error age was 55.8 ± 0.5 years, disease duration 18.2 ± 1.0 years and EDSS score 5.5 ± 0.1. Disease duration, the number of steroid courses per disease duration, weight, BMI and physical activity did not differ according to the four disability groups. The mean waist circumference increased significantly with increased severity of EDSS, p = 0.03. Increased disability in individuals with MS was not correlated with disease duration, lifestyle habits or overweight/obesity. However, increased disability was associated with central obesity.
- Published
- 2021
41. Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood
- Author
-
Gal Puris, Arnon Afek, Aya Bardugo, Itamar Raz, Dorit Tzur, Amir Tirosh, Miri Lutski, Orit Pinhas-Hamiel, Cole D. Bendor, Ofri Mosenzon, Tali Cukierman-Yaffe, Meir Schechter, Gilad Twig, Inbar Zucker, Hertzel C. Gerstein, and Estela Derazne
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Goiter ,Diabetes risk ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,030209 endocrinology & metabolism ,Type 2 diabetes ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Thyroid Function Tests ,Biochemistry ,Thyroid function tests ,Risk Assessment ,Body Mass Index ,Cohort Studies ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Endocrinology ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Registries ,Risk factor ,Israel ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Thyroid ,medicine.disease ,Thyroid Diseases ,medicine.anatomical_structure ,Diabetes Mellitus, Type 2 ,Socioeconomic Factors ,Female ,business ,Body mass index ,Follow-Up Studies - Abstract
Context Thyroid hormones play a key role in systemic metabolism, yet the relationship between thyroid dysfunction and risk for type 2 diabetes is unclear. Objective To assess type 2 diabetes risk in adulthood among adolescents with thyroid disorders. Design and Setting A nationwide, population-based study of Israeli adolescents who were examined before military recruitment during 1988 to 2007 and were followed until December 31, 2016. Participants 1 382 560 adolescents (mean age 17.3 years). Interventions The diagnosis of thyroid disorders was based on recent thyroid function tests. Data were linked to the Israeli National Diabetes Registry. Cox proportional hazard models were applied. Main Outcome Measures Type 2 diabetes incidence. Results During a mean follow-up of 18.5 years, 1.12% (69 of 6,152) of adolescents with thyroid disorders were diagnosed with type 2 diabetes vs 0.77% of adolescents without thyroid disorders. The hazard ratio (HR) for type 2 diabetes was 2.3 (95% CI, 1.8-2.9) among those with thyroid disorders, after adjustment for sex, birth-year, body mass index, and sociodemographic confounders. The increased diabetes risk was observed in both men and women, with the presence or absence of obesity, and in the absence of other health conditions and was associated with different types of thyroid disorders. It was also similar when the outcome was defined as type 2 diabetes diagnosed at or before the age of 30 years (HR 2.3, 95% CI, 1.5-3.5). Conclusions Thyroid disorders diagnosed in adolescence are a risk factor for early-onset type 2 diabetes in both men and women.
- Published
- 2021
42. Asthma in Youth and Early-onset Type 2 Diabetes: A Nationwide Study of 1.72 Million Israeli Adolescents
- Author
-
Arnon Afek, Itamar Raz, Amir Tirosh, Michael Shapiro, Gilad Twig, Ofri Mosenzon, Hertzel C. Gerstein, Estela Derazne, Orit Pinhas-Hamiel, Chen Arbel, Tali Cukierman-Yaffe, Dorit Tzur, Inbar Zucker, Gingy Ronen Balmor, Vered Rosenberg, Zivan Beer, Gabriel Chodick, and Miri Lutski
- Subjects
Spirometry ,Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Pediatric Obesity ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,Type 2 diabetes ,Biochemistry ,Severity of Illness Index ,Body Mass Index ,Young Adult ,Endocrinology ,Risk Factors ,Diabetes mellitus ,Internal medicine ,medicine ,Prevalence ,Humans ,Registries ,Young adult ,Israel ,education ,Asthma ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Odds ratio ,medicine.disease ,Prognosis ,Diabetes Mellitus, Type 2 ,Female ,business ,Body mass index ,Biomarkers ,Follow-Up Studies - Abstract
Background The prevalence of both asthma and early-onset diabetes is on the rise; however, the association between them remains unclear. We examined a possible association of asthma at adolescence with type 2 diabetes in young adulthood. Methods This is a nationwide, population-based study of 1 718 541 Israeli adolescents (57% males; mean age 17.3 years; range 16-19 years), examined before compulsory military service between 1992 and 2016, with data linked to the Israeli National Diabetes Registry. Asthma diagnosis and severity were determined by a board-certified pulmonologist and based on spirometry tests. Results Type 2 diabetes developed in 58/9090 (0.64%), 507/97 059 (0.52%), 114/23 332 (0.49%), and 7095/1 589 060 (0.44%) persons with moderate-to-severe, mild, inactive, and no history of asthma, respectively, during a mean follow-up >13 years. The respective odds ratios (ORs) were 1.33 (95% CI, 1.02-1.74), 1.17 (1.06-1.28), and 1.09 (0.9-1.31), considering those without asthma history as the reference, in a model adjusted for birth year, sex, body mass index, and other sociodemographic variables. The association persisted when the analysis accounted for coexisting morbidities, and when persons without asthma, individually matched by age, sex, birth year, and body mass index were the reference. Both mild and moderate-to-severe asthma were associated with type 2 diabetes before age 35 years: ORs 1.18 (1.05-1.34) and 1.44 (1.05-2.00), respectively. The strength of the association was accentuated over time. The effect was unchanged when adjusted for oral and inhaled glucocorticoid use. Conclusion Adolescents with active asthma have higher risk to develop type 2 diabetes. This seems related to disease severity, independent of adolescent obesity status, apparent before age 35 years, and more pronounced in recent years.
- Published
- 2020
43. Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Author
-
Orit Pinhas-Hamiel MD
- Subjects
General Economics, Econometrics and Finance - Published
- 2020
44. Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder
- Author
-
Eve Stern, Dikla Pivko-Levy, Shahar Miller, Chana Graf-Barel, Yael Levy-Shraga, Michal Ben-Ami, Noa Levek, Noah Gruber, Rachel Frumkin Ben-David, Michal Yackobovitch-Gavan, Dalit Modan-Moses, Kineret Mazor-Aronovitch, Tal Ben-Ari, Zohar Landau, and Orit Pinhas-Hamiel
- Subjects
Blood Glucose ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Context (language use) ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Diabetes mellitus ,Surveys and Questionnaires ,mental disorders ,Internal Medicine ,medicine ,Attention deficit hyperactivity disorder ,Humans ,Hypoglycemic Agents ,Insulin ,030212 general & internal medicine ,Child ,Glycemic ,Type 1 diabetes ,business.industry ,medicine.disease ,Ketoacidosis ,Hospitalization ,Cross-Sectional Studies ,Diabetes Mellitus, Type 1 ,Attention Deficit Disorder with Hyperactivity ,Case-Control Studies ,Pediatrics, Perinatology and Child Health ,Quality of Life ,Dual diagnosis ,Female ,business - Abstract
Background Data regarding glycemic control in children and adolescents with a dual diagnosis of type 1 diabetes mellitus (T1DM) and attention-deficit/hyperactivity disorder (ADHD) are limited. Objective To compare various aspects of diabetes control among youth with T1DM, between those with and without ADHD. Methods In this cross-sectional study of youth with T1DM, 39 had ADHD (mean age 14.1 ± 2.8 years) and 82 did not (control group, mean age 12.6 ± 3.3 years). Health-related quality of life was assessed by a Diabetes Quality of Life (DQOL) questionnaire submitted to their parents. Glycemic data were downloaded from glucometers, pumps, and continuous glucose monitoring systems. HbA1c levels, hospitalizations, and severe hypoglycemic and diabetes ketoacidosis events were retrieved from the medical files. Results Compared to the control group mean HbA1c level of the ADHD group was higher: 8.3 ± 1.1% versus 7.7 ± 1.0% (p = 0.005) and the percent of time that glucose level was in the target range (70-180 mg/dl) was lower: 48 ± 17% versus 59 ± 14% (p = 0.006). Mean glucose and glucose variability were higher in the ADHD group. Youth with ADHD who were not pharmacologically treated had worse HbA1c and more hospitalizations than those who were treated. DQOL did not differ between the control group, the treated ADHD group, and the untreated ADHD-Group. Conclusions Dual diagnosis of T1DM and ADHD during childhood leads to worse diabetes control, which is more pronounced in the context of untreated ADHD. Healthcare providers should be aware of the difficulties facing youth with T1DM and ADHD in coping with the current intensive treatment of diabetes.
- Published
- 2020
45. Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy in Children and Adolescents with Type 2 Diabetes
- Author
-
Orit Pinhas-Hamiel and Daniel Hamiel
- Subjects
0301 basic medicine ,Adult ,Male ,endocrine system ,Mindfulness ,endocrine system diseases ,Adolescent ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Psychological intervention ,030209 endocrinology & metabolism ,Acceptance and commitment therapy ,03 medical and health sciences ,0302 clinical medicine ,Internal Medicine ,medicine ,Humans ,Acceptance and Commitment Therapy ,Child ,Mindfulness-based cognitive therapy ,Glycemic ,Cognitive Behavioral Therapy ,business.industry ,nutritional and metabolic diseases ,Cognitive behavioral therapy ,030104 developmental biology ,Diabetes Mellitus, Type 2 ,Psychotherapy, Group ,Anxiety ,Health education ,Female ,medicine.symptom ,business ,human activities ,Clinical psychology - Abstract
Among adults with type 2 diabetes (T2D), cognitive behavioral therapy (CBT), acceptance and commitment therapy, and mindfulness interventions have demonstrated improvement in depression, anxiety, and glycemic control. We assessed whether these treatment modalities have shown usefulness in adolescents with T2D or at risk for T2D. Data are limited on the use of the abovementioned therapeutic interventions and include only adolescent girls at risk for T2D. CBT was as useful as health education sessions. At 1 year, greater decreases in depression, insulin resistance, and BMI were observed in girls randomized to mindfulness compared with CBT groups. Given the positive outcome of mindfulness intervention in adults and in adolescent girls at risk for T2D, future studies should involve males at risk for T2D, and adolescents diagnosed with T2D. Longer interventions and booster meetings for maintenance should be studied.
- Published
- 2020
46. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
- Author
-
Galia Barash, Kineret Mazor-Aronovitch, Zohar Landau, Michal Dekel, Neria Levran, Orit Pinhas-Hamiel, Yael Lebenthal, Efrat Chorna, Avivit Brener, Marianna Rachmiel, and Noa Levek
- Subjects
Blood Glucose ,Male ,CGM metrics ,Telemedicine ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Population ,030209 endocrinology & metabolism ,Telehealth ,Glycemic Control ,030204 cardiovascular system & hematology ,Adolescents ,Time-in-range ,Cohort Studies ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Clinical endpoint ,Internal Medicine ,Medicine ,Humans ,Young adult ,Israel ,education ,Child ,Children ,education.field_of_study ,Type 1 diabetes ,business.industry ,Blood Glucose Self-Monitoring ,COVID-19 ,Odds ratio ,General Medicine ,medicine.disease ,Diabetes Mellitus, Type 1 ,Child, Preschool ,Communicable Disease Control ,Female ,Original Article ,business - Abstract
Aims Children with chronic diseases were unable to receive their usual care during COVID-19 lockdown. We assessed the feasibility and impact of telehealth visits on the time-in-range (TIR) of paediatric individuals with type 1 diabetes (T1D). Methods An observational multicentre real-life study. Patients scheduled for an in-clinic visit during the lockdown were offered to participate in a telehealth visit. Sociodemographic, clinical, continuous glucose monitor and pump data were recorded 2 weeks prior and 2 weeks after telehealth visit. The primary endpoint was change in relative-TIR, i.e. change in TIR divided by the percent of possible change (∆TIR/(100-TIRbefore)*100). Results The study group comprised 195 individuals with T1D (47.7% males), mean±SD age 14.6 ± 5.3 years, and diabetes duration 6.0 ± 4.6 years. Telehealth was accomplished with 121 patients and their parents (62.0%); 74 (38.0%) did not transfer complete data. Mean TIR was significantly higher for the two-week period after the telehealth visit than for the two-week period prior the visit (62.9 ± 16.0, p < 0.001 vs. 59.0 ± 17.2); the improvement in relative-TIR was 5.7±26.1%. Initial higher mean glucose level, lower TIR, less time spent at
- Published
- 2020
47. Adolescent BMI and Early-Onset Type 2 Diabetes Among Ethiopian Immigrants and Their Descendants: A Nationwide Study
- Author
-
Estela Derazne, Orit Pinhas-Hamiel, Ofri Mosenzon, Doron M. Behar, Gilad Twig, Inbar Zucker, Amir Tirosh, Tali Cukierman-Yaffe, Maya Simchoni, Zivan Beer, Dorit Tzur, Uri Hamiel, Miri Lutski, Lital Keinan-Boker, Arnon Afek, and Itamar Raz
- Subjects
Male ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Pediatric Obesity ,medicine.medical_specialty ,Adolescent ,Epidemiology ,Endocrinology, Diabetes and Metabolism ,Black People ,Emigrants and Immigrants ,Immigration ,Type 2 diabetes ,Overweight ,Adolescents ,Risk Assessment ,Body Mass Index ,Young Adult ,BMI ,Sex Factors ,Risk Factors ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Longitudinal Studies ,Age of Onset ,Israel ,Risk factor ,Original Investigation ,Early-onset ,Proportional hazards model ,business.industry ,Incidence ,Incidence (epidemiology) ,Hazard ratio ,medicine.disease ,Diabetes Mellitus, Type 2 ,lcsh:RC666-701 ,Cohort ,Female ,Ethiopia ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Demography - Abstract
Background We assessed in a nationwide cohort the association between adolescent BMI and early-onset ( Methods Normoglycemic adolescents (range 16–20 years old), including 93,806 native Israelis (≥ 3rd generation in Israel) and 27,684 Israelis of Ethiopian origin, were medically assessed for military service between 1996 and 2011. Weight and height were measured. Data were linked to the Israeli National Diabetes Registry. Incident type 2 diabetes by December 31, 2016 was the outcome. Cox regression models stratified by sex and BMI categories were applied. Results 226 (0.29%) men and 79 (0.18%) women developed diabetes during 992,980 and 530,814 person-years follow-up, respectively, at a mean age of 30.4 and 27.4 years, respectively. Among native Israeli men with normal and high (overweight and obese) BMI, diabetes incidence was 9.5 and 62.0 (per 105 person-years), respectively. The respective incidences were 46.9 and 112.3 among men of Ethiopian origin. After adjustment for sociodemographic confounders, the hazard ratios for type 2 diabetes among Ethiopian men with normal and high BMI were 3.4 (2.3–5.1) and 15.8 (8.3–30.3) respectively, compared to third-generation Israelis with normal BMI. When this analysis was limited to Israeli-born Ethiopian men, the hazard ratios were 4.4 (1.7–11.4) and 29.1 (12.9–70.6), respectively. Results persisted when immigrants of other white Caucasian origin were the reference; and among women with normal, but not high, BMI. Conclusions Ethiopian origin is a risk factor for early-onset type 2 diabetes among young men at any BMI, and may require selective interventions.
- Published
- 2020
48. Socioeconomic inequalities and severe obesity—Sex differences in a nationwide study of 1.12 million Israeli adolescents
- Author
-
Arnon Afek, Dorit Tzur, Gilad Twig, Uri Hamiel, Tarif Bader, Orit Pinhas-Hamiel, Estela Derazne, Brian Reichman, and Khitam Muhsen
- Subjects
Male ,0301 basic medicine ,Adolescent ,Population ,030209 endocrinology & metabolism ,Overweight ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Class II obesity ,Class I obesity ,medicine ,Humans ,Israel ,education ,Sex Characteristics ,education.field_of_study ,030109 nutrition & dietetics ,Nutrition and Dietetics ,business.industry ,Class III obesity ,Health Policy ,Public Health, Environmental and Occupational Health ,Odds ratio ,medicine.disease ,Obesity ,Obesity, Morbid ,Social Class ,Pediatrics, Perinatology and Child Health ,Cohort ,Female ,medicine.symptom ,business ,Demography - Abstract
Introduction In a nationwide population of adolescents, we investigated the sex-specific association of socioeconomic position (SEP) with severe obesity, and trends over time. Methods The cohort comprises all Israeli adolescents (mean ± SD age 17.3 ± 0.5 years) who were medically examined, before mandatory military service during 2000 to 2015. Of 1 120 362 adolescents, 239 816 (21.4%) were classified with overweight or with obesity classes I to III using the International Obesity Task Force criteria. Data were compared between 2000 to 2009 and 2010 to 2015. Results Considering more advantaged residential SEP as the reference group, the respective odds ratios (ORs ± 95%CI) of less advantaged SEP for obesity classes I to III in 2010 to 2015 were 1.48 (1.40-1.56), 1.66 (1.51-1.83), and 1.73 (1.45-2.08) for males; and 1.72 (1.60-1.84), 1.89 (1.66-2.15), and 2.62 (2.04-3.37) for females. All point estimates were higher than in the preceding decade. Considering female inductees from the more advantaged SEP as the reference group, ORs were higher for males in the more advantaged SEP group, for overweight, 1.31 (1.27-1.36); class I obesity, 1.29 (1.20-1.38); class II obesity, 1.34 (1.18-1.53); and class III obesity, 1.60 (1.24-2.07). Similarly, in the less and medium advantaged SEP groups, increased ORs for males compared with females were observed in all obesity groups. Results persisted using United States Centers for Disease Control and Prevention growth charts. Conclusions Adolescents with less rather than more advantaged residential SEP are at greater risk of severe obesity. Adolescent males, of all residential SEP groups had higher odds than females for all classes of obesity.
- Published
- 2020
49. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
- Author
-
Cole D. Bendor, Arnon Afek, Gilad Twig, Aya Bardugo, and Orit Pinhas-Hamiel
- Subjects
Male ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Pediatric Obesity ,Pediatrics ,Time Factors ,Youth ,Endocrinology, Diabetes and Metabolism ,Comorbidity ,Review ,Type 2 diabetes ,Disease ,Cardiovascular ,Severity of Illness Index ,Body Mass Index ,Morbid obesity ,Risk Factors ,Neoplasms ,Epidemiology ,Prevalence ,Young adult ,Child ,Adiposity ,Cancer ,Diabetes ,Age Factors ,Prognosis ,Adolescence ,Cardiovascular Diseases ,Child, Preschool ,Hypertension ,Female ,Severe obesity ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,Adolescent ,Risk Assessment ,Young Adult ,NAFLD ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Humans ,Mortality ,business.industry ,Public health ,Paediatrics ,medicine.disease ,Obesity ,lcsh:RC666-701 ,business ,Dyslipidemia - Abstract
Severe obesity among children and adolescents is a significant global public health concern. The prevalence has markedly increased over the last decades, becoming common in many countries. Overwhelming rates of obesity among youth have prompted efforts to identify an evidence-based immediate- and long-term cardiometabolic risk factor profile in childhood-onset severe obesity, and to highlight gaps that require further investigation. The PubMed database was systematically searched in accordance with PRISMA guidelines. The search yielded 831 results, of which 60 fulfilled stringent criteria and were summarized in this review. The definition of severe obesity was variable, with only one half the publications using the definition BMI > 120% of the 95th percentile. Point estimates of the prevalence of at least one cardiometabolic risk factor in children with severe obesity reportedly range from 67 to 86%. Cross-sectional studies indicate that children and adolescents with severe obesity are at greater risk than those with mild obesity for type 2 diabetes, hypertension, fatty liver disease and dyslipidemia, already at childhood and adolescence. Robust epidemiological data on the long-term risk and actual point estimates in adulthood are lacking for these diseases as well as for other diseases (coronary heart disease, stroke, chronic kidney disease and cancer). Recent longitudinal studies indicate an increased risk for cardiomyopathy, heart failure, cardiovascular mortality and all-cause mortality in adulthood for adolescents with severe obesity compared to those with mild obesity. Given the alarming increase in the prevalence of severe obesity, the persistence of adiposity from childhood to adulthood and the precarious course of young adults with chronic comorbidities, the economic and clinical services burden on the healthcare system is expected to rise.
- Published
- 2020
50. 720-P: Prurigo Pigmentosa: An Acute Complication of Ketogenic Diet
- Author
-
Noa Levek, Kineret Mazor-Aronovitch, Orit Pinhas-Hamiel, Efrat Monsonego-Ornan, Neriya Levran, Bruria Sher, Zohar Landau, Elinor Mauda, and Shoshana Grenberger
- Subjects
Insulin pump ,medicine.medical_specialty ,Type 1 diabetes ,Prurigo pigmentosa ,Side effect ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,medicine.disease ,Rash ,Dermatology ,Internal Medicine ,medicine ,Ketosis ,medicine.symptom ,business ,Ketogenic diet ,Glycemic - Abstract
A 22-year old female with type 1 diabetes (T1DM) presented with generalized rash. She was diagnosed at the age of 9 years and is treated with insulin pump and CGMS (continues glucose monitoring sensors), her recent HbA1c was 7.4%. Four weeks prior to her rash presentation she started a low carbohydrate diet (50 gr of carbs per day) in order to improve her glycemic control. Pruritic erythematous papules, papulovesicular, and vesicles appeared on her axillary region, upper back and groins. Lesions were associated with severe pruritus and negatively affected her quality of life. Various therapies were initiated by dermatologist as: antifungal agent, Itraconazole, and Betamethasone Esters, without any improvement. Her serum beta-hydroxybutyrate levels were between 1.1-1.2 mmol/l. Prurigo pigmentosa, a rare pruritic inflammatory dermatosis secondary to her high ketones levels was diagnosed. Her condition resolved after she increased her carbohydrate intake to 75 gr per day. Beta-hydroxybutyrate level decreased concomitantly to 0.1-0.2 mmol/l. When carbohydrate restriction was rechallenged, she again entered ketosis, followed by recurrence of the pruritic lesions. Carbohydrate intake was increased and subsequently all lesions resolved with remaining reticular hyperpigmentation. During the last few years low carb diets have gained popularity among patients with T1DM. This case illustrates the rare side effect of high ketones body levels. Health care providers should be familiar with this side effect. Disclosure N. levran: None. K. Mazor-Aronovitch: None. S. Grenberger: None. N. Levek: None. B. Sher: None. E. Mauda: None. Z. Landau: None. E. Monsonego-Ornan: None. O. Pinhas-Hamiel: None.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.